Zimmer Biomet Approves Amendments at Annual Meeting

Zimmer Biomet Holdings ( (ZBH) ) has shared an announcement.

Zimmer Biomet Holdings, Inc. held its annual meeting on May 29, 2025, where shareholders approved significant amendments to the 2009 Stock Incentive Plan (SIP) and the company’s Restated Certificate of Incorporation. The amendments to the SIP include an increase in available shares, extension of the plan’s term, and new provisions for independent contractors, among others. The amendment to the Certificate of Incorporation limits the personal liability of certain officers for monetary damages under specific circumstances. These changes are expected to enhance corporate governance and align with best practices, potentially impacting the company’s operational and strategic positioning.

The most recent analyst rating on (ZBH) stock is a Buy with a $130.00 price target. To see the full list of analyst forecasts on Zimmer Biomet Holdings stock, see the ZBH Stock Forecast page.

Spark’s Take on ZBH Stock

According to Spark, TipRanks’ AI Analyst, ZBH is a Outperform.

Zimmer Biomet’s solid financial performance is a key strength, supported by strategic cash flow management and stable leverage. However, technical indicators point to bearish momentum, and valuation metrics suggest moderate investment appeal. The newly appointed executive leadership could provide future growth opportunities, balancing the current challenges from tariffs and lowered EPS guidance.

To see Spark’s full report on ZBH stock, click here.

More about Zimmer Biomet Holdings

Average Trading Volume: 2,362,984

Technical Sentiment Signal: Sell

Current Market Cap: $18.03B

For detailed information about ZBH stock, go to TipRanks’ Stock Analysis page.